First Time Loading...

Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 43.99 USD 0.66% Market Closed
Updated: May 4, 2024

Bristol-Myers Squibb Co
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bristol-Myers Squibb Co
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
PFE
MRK
ZTS
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
$8.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$21.4B
CAGR 3-Years
-46%
CAGR 5-Years
-3%
CAGR 10-Years
-10%
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-12%
CAGR 5-Years
17%
CAGR 10-Years
-5%
Zoetis Inc
NYSE:ZTS
Cash from Financing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-32%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$2.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bristol-Myers Squibb Co's Cash from Financing Activities?
Cash from Financing Activities
8.3B USD

Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Cash from Financing Activities amounts to 8.3B USD.